Guidelines for Laboratory Biosafety: Handling and Processing Specimens Associated with Novel Influenza A Viruses, Including Potential A(H5N1) VirusCDC
Covers the use of personal protective equipment, testing, antiviral treatment, patient investigations, monitoring of exposed persons, and antiviral chemoprophylaxis of exposed persons
Highly Pathogenic Avian Influenza A(H5N1) Virus in Animals: Interim Recommendations for Prevention, Monitoring, and Public Health InvestigationsCDC
Covers the use of personal protective equipment, testing, antiviral treatment, patient investigations, monitoring of exposed persons, and antiviral chemoprophylaxis of exposed persons
Early Treatment with Pegylated Interferon Lambda for Covid-19 (Website)The New England Journal of Medicine (NEJM)
9 February 2023
Reis G, et.al.
Among predominantly vaccinated outpatients with Covid-19, the incidence of hospitalization or an emergency department visit was significantly lower among those who received a single dose of pegylated interferon lambda than among those who received placebo.
Monkeypox: The State of the ScienceAmerican Public Health Association (APHL)/National Academy of Medicine
24 August 2022
MONKEYPOX: An old disease in new places -- where do we go from here?Texas Epidemic Public Health Institute (TEPHI) - Grand Rounds
3 August 2022
Susan McLellan, MD, MPH
Monkeypox: Updates on Testing, Vaccination & TreatmentCDC/Infectious Diseases Society of America (IDSA)
23 July 2022
Webinar